Semaglutide was FDA-approved for weight loss in 2021 and it has been shown to reduce body weight by at least 15% in 8 weeks
Within GLP-1 receptor research, it remains a benchmark compound for comparator studies in laboratories worldwide
Strong food noise, cravings, or appetite dysregulation that has not responded well to nutrition changes alone
In addition, mood abnormalities are common [2], particularly despair and anxiety [23], whereas 58.4% of Long COVID patients have cognitive impairment and 3451-78% have memory problems, particularly memory loss [2, 18, 22, 104, 108]
Unlike figure 1, this extends beyond the first AOM named by each doctor to include all AOMs named and is specific to the brand name (apart from for orlistat, where the INN is included)